ERX Pharmaceuticals
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity. (NCT07570758) | ERX Pharmaceuticals | 2026-05-28 |
| ERX1000 - Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Male and Female Subjects With Obesity (NCT04890873) | ERX Pharmaceuticals | 2019-10-17 |
Track ERX Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.